4//SEC Filing
WILSON JOHN S 4
Accession 0001415889-12-001655
CIK 0001374328other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 8:15 PM ET
Size
14.2 KB
Accession
0001415889-12-001655
Insider Transaction Report
Form 4
BOND LABORATORIES, INC.BNLB.OB
WILSON JOHN S
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Purchase
Common Stock
2012-11-06+1,399,352→ 2,649,006 total - Purchase
Series B Convertible Preferred Stock
2012-11-06+8.77→ 8.77 totalExercise: $0.00→ Common Stock (526,200 underlying)
Holdings
- 500,000
Stock Option
Exercise: $0.09From: 2012-05-09Exp: 2017-04-13→ Common Stock - 500,000
Stock Option
Exercise: $0.10From: 2011-06-08Exp: 2021-06-08→ Common Stock (500,000 underlying) - 1,000,000
Warrant
Exercise: $0.15From: 2008-12-31Exp: 2013-12-31→ Common Stock (1,000,000 underlying) - 16.7
Series C Convertible Preferred Stock
Exercise: $0.25→ Common Stock (668,000 underlying) - 332,500
Warrant
Exercise: $0.30Exp: 2015-11-15→ Common Stock (332,500 underlying)
Footnotes (5)
- [F1]Mr. Wilson acquired the shares of common stock, as well as the shares of Series B Convertible Preferred Stock reported in Table II ("Series B Preferred"), for aggregate consideration of $50,000, in a private transaction.
- [F2]The Series B Preferred convert, without additional consideration, into shares of the Issuer's common stock on a 1-for-60,000 basis.
- [F3]The Series B Preferred, Series C Convertible Preferred Stock ("Series C Preferred") and Warrants are immediately convertible, or exercisable, as the case may be.
- [F4]The Series B Preferred and Series C Preferred are perpetual.
- [F5]The Series C Preferred convert on a 1-for-40,000 basis.
Documents
Issuer
BOND LABORATORIES, INC.
CIK 0001374328
Entity typeother
Related Parties
1- filerCIK 0001497703
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 8:15 PM ET
- Size
- 14.2 KB